Study Group: Physicians who Treat Graft-versus-Host disease(?)
Council Members in this Study Group: 49
Request a survey with this Study Group
Leading Experts in this Study Group
Donald Fleming, MD
Division Head of Hematology and Oncology
Davis Health System, Inc.
Donald Fleming, MD, is the Head of Hematology-Oncology at the Medical Center of Vincennes. Previously, Dr. Fleming was a Tenured Professor in the Division of Hematology-Oncology at University of Louisville. He has published over 25 manuscripts in peer-reviewed journals and remains involved in clinical...
Robert Aris, MDAssociate Professor of Medicine
University of North Carolina Chapel Hill - CC
Robert Aris, MD, is an Associate Professor of Medicine at the University of North Carolina Chapel Hill. He is the Director of the Pulmonary Hypertension Program, the Lung Transplant Research Program and Inpatient Pulmonary Services. Dr. Aris has expertise in advanced lung diseases including cystic...
Staff Physician
Ironwood Cancer & Research Center
Sujith Kalmadi, MD, is a Staff Physician at the Ironwood Cancer and Research Center in Phoenix, Arizona. Dr. Kalmadi has previously worked as a Clinical Assistant Professor at Baylor school of Medicine in Houston, Texas, and at the Lerner School of Medicine at the Cleveland Clinic, Ohio. He has interest...
Hepatologist and Gastroenterologist
Miami Gastroenterology Consultants PA
Miguel Rodriguez, MD, is a Hepatologist & Gastroenterologist, Managing Partner of Miami Gastroenterology Consultants, PA., a single specialty group in Miami, Florida. He is former Assistant Professor of Medicine of the University of Miami School of Medicine and Center for Liver Diseases and Division...
Instructor in Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Eric Jacobsen, MD, is a Medical Oncologist and Hematologist in the Hematology/Oncology Department at the Dana Farber Cancer Institute in Boston, MA. His clinical focus is on lymphoma, and he is very involved in Phase II/III clinical trials for new compounds, as well as stem cell transplantation.
Assistant Professor of Medicine
University of Pennsylvania Cancer Center
Donald Tsai, MD, PhD, is Assistant Professor of Medicine at the University of Pennsylvania Cancer Center. Dr. Tsai specializes in the treatment of hematological malignancies such as leukemia, multiple myeloma, lymphoma, Hodgkin's disease, myelodysplastic syndromes (MDS), and bone marrow transplantation....
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Satistics are usually used to reveal dramatic differences Patients often misinterpret relative differences for absolute ones patients are willing to do a lot more to get any benefit in cancer outcome
Many studies support EGFR response correlates with rash Many attempts to actually increase the incidence of rash Most patients will use the EGFR treatments despite the rash
This phase III study was done without the benefit of conventional drug development with Phase I and Phase II studies (which would have provided more information about the effective dose) preceding it because pharmacokinetic date from IV and SC dosing studies were used to extrapolate for the...
Saturn trial attempted to focus on EGFR reative patients Saturn was positive as a maintenance therapy, while concurrent was not
TKI's have been establihed in a small number of refractory solid cancers With slow migration to other venues, we are seeing new applications
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Office Based Private Practice or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Professor
- Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms